Periprosthetic Loss of Bone Mineral Density After Cementless Porous Tantalum and Cemented Total Knee Arthroplasties: A Mean of 11-Year Concise Follow-Up of a Previous Report.


Journal

The Journal of arthroplasty
ISSN: 1532-8406
Titre abrégé: J Arthroplasty
Pays: United States
ID NLM: 8703515

Informations de publication

Date de publication:
11 2020
Historique:
received: 30 04 2020
revised: 31 05 2020
accepted: 09 06 2020
pubmed: 8 7 2020
medline: 7 4 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Our previous study showed that the decrease in relative change of bone mineral density (BMD) in the lateral part of the tibia was significantly less in the group treated with the cementless porous tantalum component than in the group treated with the cemented cobalt-chromium tibial component up to 5 years after the operation. However, the long-term benefits of porous tantalum tibial component on BMD have not been proven. The aim of this study was to update a matched cohort study at a minimum of 6 years' follow-up period. Twenty patients with a porous tantalum tibial component and 18 patients with a cemented cobalt-chromium-alloy tibial component were investigated for more than 6 years in the present study. The mean follow-up period was 11.4 years. Dual X-ray absorptiometry was used to measure the BMD. The decrease in relative change of BMD in the lateral aspect of the tibia was significantly less with the porous tantalum tibial component than that with the cemented cobalt-chromium tibial component up to 5 years. However, at the final follow-up period, no significant difference was observed in the relative change of BMD between the 2 groups. No prosthetic migration or periprosthetic fracture was detected in either group. The present study is one of the studies with the longest follow-up period on BMD after total knee arthroplasty. Porous tantalum tibial component did not have a favorable effect on the BMD of the proximal tibia after total knee arthroplasty for long term.

Sections du résumé

BACKGROUND
Our previous study showed that the decrease in relative change of bone mineral density (BMD) in the lateral part of the tibia was significantly less in the group treated with the cementless porous tantalum component than in the group treated with the cemented cobalt-chromium tibial component up to 5 years after the operation. However, the long-term benefits of porous tantalum tibial component on BMD have not been proven. The aim of this study was to update a matched cohort study at a minimum of 6 years' follow-up period.
METHODS
Twenty patients with a porous tantalum tibial component and 18 patients with a cemented cobalt-chromium-alloy tibial component were investigated for more than 6 years in the present study. The mean follow-up period was 11.4 years. Dual X-ray absorptiometry was used to measure the BMD.
RESULTS
The decrease in relative change of BMD in the lateral aspect of the tibia was significantly less with the porous tantalum tibial component than that with the cemented cobalt-chromium tibial component up to 5 years. However, at the final follow-up period, no significant difference was observed in the relative change of BMD between the 2 groups. No prosthetic migration or periprosthetic fracture was detected in either group.
CONCLUSION
The present study is one of the studies with the longest follow-up period on BMD after total knee arthroplasty. Porous tantalum tibial component did not have a favorable effect on the BMD of the proximal tibia after total knee arthroplasty for long term.

Identifiants

pubmed: 32631727
pii: S0883-5403(20)30654-9
doi: 10.1016/j.arth.2020.06.014
pii:
doi:

Substances chimiques

Tantalum 6424HBN274

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3156-3160

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Yukihide Minoda (Y)

Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Akio Kobayashi (A)

Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan; Department of Orthopaedic Surgery, Shiraniwa Hospital, Ikoma, Nara, Japan.

Mitsuhiko Ikebuchi (M)

Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Hiroyoshi Iwaki (H)

Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Fumiaki Inori (F)

Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Hiroaki Nakamura (H)

Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH